T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis

Abstract

Our data suggested that T-614 is an effective disease-modifying agent that can prevent bone/cartilage destruction and inflammation in in CIA rats. Combination with methotrexate markedly enhances the therapeutic effect of T-614.